Guided Therapeutics (GTHP) Gross Margin Growth (5y) (2017 - 2025)
Guided Therapeutics (GTHP) Gross Margin Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26,237.00 |
| Sep 30, 2025 | -2,608.00 |
| Dec 31, 2024 | -27,500.00 |
| Mar 31, 2024 | -2,778.00 |
| Dec 31, 2023 | 15,476.00 |
| Jun 30, 2023 | -6,250.00 |
| Mar 31, 2023 | 3,409.00 |
| Sep 30, 2022 | 29,394.00 |
| Jun 30, 2022 | 7,425.00 |
| Mar 31, 2022 | 5,619.00 |
| Dec 31, 2021 | 2,944.00 |
| Sep 30, 2021 | -13,158.00 |
| Dec 31, 2020 | -204,889.00 |
| Sep 30, 2020 | 168,442.00 |
| Dec 31, 2019 | 4,423.00 |
| Sep 30, 2019 | 9,091.00 |
| Jun 30, 2019 | -576,364.00 |
| Mar 31, 2019 | 46,287.00 |
| Dec 31, 2018 | -5,736.00 |
| Sep 30, 2018 | 16,860.00 |